✦ LIBER ✦

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

✍ Scribed by O.S. Nielsen; P. Reichardt; T.B. Christensen; D. Pink; S. Daugaard; C. Hermans; S. Marreaud; M. van Glabbeke; J. Blay; I. Judson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

695 An EORTC phase I study to determine

✍ O.S. Nielsen; P. Reichardt; D. Pink; J. Lindegaard; S. Daugaard; C. Hermans; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

1188 ORAL Final data of the EORTC phase

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Brostallicin versus doxorubicin as first

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB

1260 Multicenter parallel phase II trial

✍ P. Schöffski; J.Y. Blay; J. DeGreve; E. Brain; J.P. Machiels; J.C. Soria; S. Sle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB